Breaking News Instant updates and real-time market news.

CVS

CVS Health

$68.19

2.73 (4.17%)

, AET

Aetna

$193.60

5.42 (2.88%)

08:10
08/09/18
08/09
08:10
08/09/18
08:10

CVS Health price target raised to $90 from $84 at RBC Capital

RBC Capital analyst George Hill raised his price target on CVS Health (CVS) to $90 and kept his Outperform rating after its Q2 results. The analyst notes that the quarter benefited from expense timing, given that its FY18 outlook has been largely maintained. Hill also maintains his positive outlook on the Aetna (AET) transaction and the impact of regulatory changes on the company.

CVS

CVS Health

$68.19

2.73 (4.17%)

AET

Aetna

$193.60

5.42 (2.88%)

  • 15

    Oct

CVS CVS Health
$68.19

2.73 (4.17%)

06/29/18
MZHO
06/29/18
NO CHANGE
MZHO
CVS, Express Scripts should be bought on recent selloff, says Mizuho
Mizuho analyst Ann Hynes recommends buying shares of CVS Health (CVS) and Express Scripts (ESRX) on weakness related to the announcement Amazon (AMZN) is entering the pharmacy space with its acquisition of PillPack. PillPack is a small mail order pharmacy, similar to the mail order pharmacies embedded in CVS Caremark, Express Scripts and OptumRx, Hynes tells investors in a research note.
06/29/18
RBCM
06/29/18
NO CHANGE
Target $84
RBCM
Outperform
CVS Health price target lowered to $84 from $91 at RBC Capital
RBC Capital analyst George Hill lowered his price target on CVS Health Corp (CVS) to $84 after Amazon (AMZN) announced its entry into the pharmacy space with the acquisition of PillPack, even though he believes that the "stickiness of payer/pharmacy relationships, decreasing share of mail order, and PillPack's market share" will not cut margins in near to medium term. Hill keeps his Outperform rating on CVS, noting that it is better positioned to continue to grow its EBIT than Walgreens (WBA). The analyst also sees Amazon's entry into drug distribution raising the possibility of DOJ approval of CVS's Aetna (AET) acquisition.
07/09/18
SBSH
07/09/18
UPGRADE
Target $81
SBSH
Buy
CVS Health assumed to Buy from Neutral at Citi
Citi analyst Ralph Giacobbe upgraded CVS Health (CVS) to Buy after assuming coverage of the name. The analyst raised his price target for the shares to $81 from $68. While the execution of an integrated healthcare superstore post the pending Aetna (AET) acquisition may be a long way off, the concept will resonate with employers and individuals, Giacobbe tells investors in a research note. He believes deal integration and competitive Amazon (AMZN) risk are "somewhat overstated particularly in the context of heavily discounted valuation."
08/08/18
PIPR
08/08/18
NO CHANGE
Target $77
PIPR
Overweight
CVS rollout could drive upside to Teladoc estimates, says Piper Jaffray
Piper Jaffray analyst Sean Wieland believes CVS Health's (CVS) expanded telehealth offering could drive upside to revenue estimates in fiscal 2019 and beyond for its partner Teladoc (TDOC). Rolling out MinuteClinic to CVS's mobile app through Teladoc is "another sign of an inflection point that telemedicine is going mainstream," Wieland tells investors in a research note. The analyst reiterates an Overweight rating on Teladoc with a $77 price target.
AET Aetna
$193.60

5.42 (2.88%)

07/10/18
PIPR
07/10/18
NO CHANGE
PIPR
Risk adjuster suspension positive for Centene and Molina, says Piper Jaffray
Centers for Medicare & Medicaid Services suspending risk adjusters for the health exchange will likely cost the government and consumers more, but it could be positive for Centene (CNC) and Molina Healthcare (MOH), Piper Jaffray analyst Sarah James tells investors in a research note. Both companies are in a net payable position for 2017 and not having to pay these funds would allow the plans to retain cash, the analyst adds. James also sees a positive read-through for UnitedHealth (UNH), Aetna (AET) and Cigna (CI). The analyst finds it most likely that CMS will seek to adjust the risk adjusters in the end rather than cancel the program, but she adds the agency only has a few weeks for them to sort this out, which she feels is not enough time.
07/20/18
CHLM
07/20/18
NO CHANGE
Target $23
CHLM
Buy
Buy Natera shares on any potential post-Aetna weakness, says Craig-Hallum
Craig-Hallum analyst Alexander Nowak says news that Aetna (AET) updated its prenatal testing medical policy, deciding not to cover average risk testing, is "disappointing" given ACOG's recent stance change on average risk, telling investors he believes Aetna's decision adds risk to UnitedHealth's (UNH) upcoming review, which is scheduled for early 2019. Nowak says he continues to like the Natera (NTRA) story and long-term potential and would be buying shares on any possible post-Aetna weakness.

TODAY'S FREE FLY STORIES

BGG

Briggs & Stratton

$13.32

-0.32 (-2.35%)

14:05
12/11/18
12/11
14:05
12/11/18
14:05
Hot Stocks
Briggs & Stratton unit announces facility expansion for job site products »

Allmand Bros, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$66.32

0.42 (0.64%)

14:05
12/11/18
12/11
14:05
12/11/18
14:05
Options
XPO Logistics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$81.53

-0.93 (-1.13%)

, MCO

Moody's

$145.15

-0.75 (-0.51%)

13:55
12/11/18
12/11
13:55
12/11/18
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Financial…

COF

Capital One

$81.53

-0.93 (-1.13%)

MCO

Moody's

$145.15

-0.75 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

GE

General Electric

$6.78

-0.145 (-2.10%)

13:50
12/11/18
12/11
13:50
12/11/18
13:50
Options
Put spread in General Electric may adjust downside position »

Put spread in General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$82.62

1.19 (1.46%)

13:47
12/11/18
12/11
13:47
12/11/18
13:47
Upgrade
Kadant rating change  »

Kadant upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 20

    Dec

SHPG

Shire

$169.43

-0.69 (-0.41%)

13:39
12/11/18
12/11
13:39
12/11/18
13:39
Downgrade
Shire rating change  »

Shire downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

PVTL

Pivotal Software

$18.04

0.01 (0.06%)

, AEO

American Eagle

$19.20

-0.32 (-1.64%)

13:35
12/11/18
12/11
13:35
12/11/18
13:35
Earnings
Notable companies reporting after market close »

Notable companies…

PVTL

Pivotal Software

$18.04

0.01 (0.06%)

AEO

American Eagle

$19.20

-0.32 (-1.64%)

PLAY

Dave & Buster's

$51.20

-1.32 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

NURO

NeuroMetrix

$0.84

0.029 (3.58%)

, GSK

GlaxoSmithKline

$37.39

-0.29 (-0.77%)

13:32
12/11/18
12/11
13:32
12/11/18
13:32
Hot Stocks
NeuroMetrix reports agreement with GSK on 2019 Quell joint development program »

NeuroMetrix (NURO)…

NURO

NeuroMetrix

$0.84

0.029 (3.58%)

GSK

GlaxoSmithKline

$37.39

-0.29 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$48.74

-1.04 (-2.09%)

13:30
12/11/18
12/11
13:30
12/11/18
13:30
Periodicals
CBS meeting adjourns without discussion of Moonves probe, NY Post says »

CBS stakeholders quickly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

NBR

Nabors Industries

$2.79

0.03 (1.09%)

13:30
12/11/18
12/11
13:30
12/11/18
13:30
Options
Repeat call buying in Nabors »

Repeat call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

TPR

Tapestry

$35.13

-0.68 (-1.90%)

13:25
12/11/18
12/11
13:25
12/11/18
13:25
Options
Tapestry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCT

Arcturus Therapeutics

$5.11

(0.00%)

13:25
12/11/18
12/11
13:25
12/11/18
13:25
Conference/Events
Arcturus Therapeutics to hold a conference call »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UBER

Uber

$0.00

(0.00%)

13:22
12/11/18
12/11
13:22
12/11/18
13:22
Periodicals
Uber being sued by defunct ride-hailing 'pioneer' Sidecar, Reuters says »

Sidecar Technologies, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/11/18
12/11
13:17
12/11/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$220.34

3.68 (1.70%)

13:17
12/11/18
12/11
13:17
12/11/18
13:17
Hot Stocks
Align Technology files three additional patent infringement suits against 3Shape »

Align Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/11/18
12/11
13:16
12/11/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
12/11/18
12/11
13:15
12/11/18
13:15
General news
Treasury's $38 B 3-year auction was fairly well received »

Treasury's $38 B…

13:15
12/11/18
12/11
13:15
12/11/18
13:15
General news
Treasury Action: the 3-year yield backed up from lows »

Treasury Action: the…

13:05
12/11/18
12/11
13:05
12/11/18
13:05
General news
3-Yr Note Auction CUSIP Number data reported »

3-Yr Note Auction CUSIP…

13:05
12/11/18
12/11
13:05
12/11/18
13:05
General news
3-Yr Note Auction Total Amount data reported »

3-Yr Note Auction Total…

13:05
12/11/18
12/11
13:05
12/11/18
13:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

WYNMF

Wynn Macau

$0.00

(0.00%)

12:51
12/11/18
12/11
12:51
12/11/18
12:51
Downgrade
Wynn Macau rating change  »

Wynn Macau downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHYY

Sands China

$0.00

(0.00%)

12:51
12/11/18
12/11
12:51
12/11/18
12:51
Downgrade
Sands China rating change  »

Sands China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLCO

Melco Resorts & Entertainment

$17.59

0.58 (3.41%)

12:50
12/11/18
12/11
12:50
12/11/18
12:50
Options
Melco Resorts calls active as shares rally 3.7% »

Melco Resorts calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.19

0.055 (0.27%)

, LBTYA

Liberty Global

$22.70

-0.96 (-4.06%)

12:46
12/11/18
12/11
12:46
12/11/18
12:46
Hot Stocks
EU opens in-depth probe into Vodafone's proposed purchase of Liberty assets »

The European Commission…

VOD

Vodafone

$20.19

0.055 (0.27%)

LBTYA

Liberty Global

$22.70

-0.96 (-4.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.